Tag : Alzheon

Clinical Research, Pharma & Healthcare Financing

Alzheon to Present ALZ-801 Trial Results at 2026 AD/PD

Business Wire
by Business Wire029
Alzheon Reports Valiltramiprosate Shows Promise as an Oral Potentially Disease-Modifying Agent to Slow Alzheimer’s Disease Based on Clinical, MRI, and Biomarker Data in APOE4/4 MCI...